White Pine Investment Company’s Arcus Biosciences RCUS Stock Holding History

White Pine Investment Company’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,939	Closed	-$660K	–	59
2021 Q3	$660K	Hold	18,939	–	–	0.23%	47
2021 Q2	$520K	Hold	18,939	–	–	0.18%	48
2021 Q1	$532K	Buy	+18,939	New	+$659K	0.2%	46
2020 Q4	–	Sell	-18,939	Closed	-$325K	–	56
2020 Q3	$325K	Buy	+18,939	New	+$423K	0.15%	47
2020 Q2	–	Sell	-18,939	Closed	-$263K	–	57
2020 Q1	$263K	Hold	18,939	–	–	0.15%	47
2019 Q4	$191K	Hold	18,939	–	–	0.08%	65
2019 Q3	$172K	Hold	18,939	–	–	0.08%	59
2019 Q2	$151K	Buy	+18,939	New	+$190K	0.07%	56
2019 Q1	–	Sell	-18,939	Closed	-$204K	–	58
2018 Q4	$204K	Buy	+18,939	New	+$221K	0.11%	50

Other funds holding RCUS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

White Pine Investment Company's RCUS Position: Q4 2021 in Review

White Pine Investment Company sold out of Arcus Biosciences (RCUS) in Q4 2021, closing a stake of 18,939 shares — an estimated $660K sold.

White Pine Investment Company first reported a position in RCUS in Q4 2018 and held it in 9 quarters. The position peaked at $660K in Q3 2021. 142 funds tracked by Wall St. Rank hold RCUS as of Q4 2021.

White Pine Investment Company reported no remaining Arcus Biosciences position as of Q4 2021 after selling out during the quarter.
White Pine Investment Company sold 18,939 Arcus Biosciences shares in Q4 2021, an estimated $660K.
White Pine Investment Company first reported a position in Arcus Biosciences in Q4 2018 and held it in 9 quarters.
White Pine Investment Company's Arcus Biosciences position peaked at $660K in Q3 2021.
142 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2021.

Based on White Pine Investment Company's 13F filing for Q4 2021, filed 28 Jan 2022.